Switch to:
More From Other Websites
Biotech Stock Selloff: Is It Justified? Mar 26 2015
The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases Mar 26 2015
Science, patients driving rare disease drug research surge Mar 25 2015
Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks Mar 25 2015
Vertex Falls on Disappointing Kalydeco+VX-661 Combo Data - Analyst Blog Mar 24 2015
Vertex Treatment May Have High Risk of Failure, Analyst Suggests Mar 24 2015
Stock Market News for March 24, 2015 - Market News Mar 24 2015
Deutsche Bank: Vertex Pharma's Disappointing VX-661 Trial Results Isn't The End Mar 23 2015
Vertex Falls Below Buy Point On Cystic-Fibrosis Drug Data Mar 23 2015
Pfizer and ImmunoGen are big market movers Mar 23 2015
Major averages dropped into the close... Mar 23 2015
Why you shouldn’t read too much into the latest Vertex trial results Mar 23 2015
Apple climbs after $1tn valuation call Mar 23 2015
ICYMI: Pharmaceutical Stocks Are Moving Big On Monday Mar 23 2015
Vertex Tumbles As Cystic Fibrosis Data Disappoints Mar 23 2015
Biotech stocks on pace to snap 8-day win streak as warnings abound Mar 23 2015
Vertex Pharmaceuticals (VRTX) Stock Falls Today on Cystic Fibrosis Drug Trial Data Mar 23 2015
Stocks Stage Low-Drama Start; Vertex Weighs On Nasdaq Mar 23 2015
Cramer's Mad Dash: Red-hot cyber play Mar 23 2015
Vertex Cystic-Fibrosis Drug Smacked by Burden of High Expectations Mar 23 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK